Список литературы 

1.      Giroud M., Gras P., Milan С. et al. Mortality of cerebral infarction with auricular )Rev. Epidemiol. Sante Publique. 1993; 41 (1): 90-96.

2.      Novello P., Ajmar G., Bianchini D. et al. Ische-mic stroke and atrial fibrillation. Ital.J. Neurol. Sci. 1993; 14 (7): 571-576.

3.      Mattle H. Long-Term Outcome after stroke due to atrial fibrilation.    Cerebrovascular. Dis.2003; 6: 3-8.

4.      Feinberg W., Blackshear J., Laupacis А. et al. Prevalence, age distribution and gender of patients with atrial fibrillation: analysis and implications. Arch.  Intern.  Med.   1995;   155:469-473.

5.      Go A., Hylek E., Phillips K. et al. Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: The anticoagulation and risk factors in atrial fibrillation. JAMA. 2001;285:2370-2375.

6.      Hart R.,  Halperin J. Atrial fibrillation and Stroke.  Concepts and controversies.  Stroke.2001;32: 803-808.

7.      Wolf P., Abbott R., Kannel W. Atrial fibrillation as an independent risk factor for stroke.Stroke. 1991; 22: 983-988. http://www. euro. who. int/document/e8 9242r.pdf

8.    Парфенов В.А. Лечение инсульта.  РМЖ. 2000; 8 (10): 426-432.

9.      Goldstein L., Adams С, Becker К. et al. Primary prevention of Ischemic Stroke. Circulation. 2001;103: 163-182.

10.    Кушаковский М.С. Аритмии сердца. С-Пб.:Фолиант. 2007; 672.

11.    Джанашия П.Х., Назаренко В.А., Николенко С.А. Мерцательная аритмия: современные концепции и тактика лечения. М.: Рос.гос. мед. ун-т. 2001; 107.

12.    Fuster  V.,   Ryden   L.,   Cannom   D.   et   al. ACC/AHA/ESC  2006  Guidelines for the management of patients with   atrial fibrillation - executive summary.  Circulation. 2006;114:700-752.

13.    Бураковский В.И., Бокерия Л.А. Руковод   ство по сердечно-сосудистой хирургии. М.:Медицина. 1989; 49.

14.    Sievert H., Lech M., Treples Т. et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation. Circulation. 2002; 105:1887-1889.

15.    Kannel W., Wolf P., Benjamin E. et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am.J. Cardiol. 1998; 82: 2-9.

16.    Fihn S., McDommel M., Matin D. et al. Riskfactors fоr complications of chronic anticoagulation: a multicenter study. Warfarin optimized outpatient follow-up study groop. Ann.Intern. Med. 1993; 118 (7): 511-520.

17.    Gorter J. For the stroke prevention in reversible  ischemia trial  (SPIRIT)  and European atrial fibrillation trial (EAFT) study groups.Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors.Neurology. 1999; 53; 1319-1327.

18.    Madden J.  Resection of the left auricular appendix. JAMA. 1948; 140: 769-772.

19.    Bailey C., Olsen A., Keown K. et al. Commisurotomy for mitral stenosis: technique for prevention of cerebral complications. JAMA. 1952;149: 1085-1091.

20.  Healey J., Crystal E., Lamy A. et. al. Left atrial appendage occlusion study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke.Am. Heart. J. 2005; 150 (2): 288-293.

21.  Bonow R., Carabello B., de Leon A. et al. ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the american college of cardiology. J. Am. Coll. Cardiol. 1998; 32: 1486-1582.

22.  OdellJ., Joseph L., Blackshear J. et. al. Toracoscopic obliteration of   the left atrial appendage: potential for stroke reduction? Ann. Thorac. Surg. 1996: 61: 565-569.

23.  Blackshear J., Jonson D., OdellJ. et. al. Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation.J. Am. Coll. Cardiol. 2003; 42:1249-1252.

24.  Ostermayer S.,  Reisman M.,  Kramer P.  Et al.    Percutaneous    left    atrial    appendage transcatheter occlusion  (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation. J. Am. Coll.Cardiol. 2005, 46: 9-14.

25.  Nakai T, Lesh M., Gesterfeld E. et al. Percutaneous  left atrial appendage  occlusion (PLAATO) for preventing cardioembolism.Circulation. 2002; 105: 2217-2222.

27.  Hanna I., Kolm P., Martin R. et al. Left atrial structure and function after percutaneous left atrial   appendage   transcatheter   occlusion (PLAATO). J.  Am.   Coll.   Cardiol.  2004;  43:1868- 872.

28.  Onalan O., Crystal E. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation. Stroke.2007; 38: 624-630.

29.  Eilen D., El-Chami M., Grow P. et al. Clinical outcomes three years after PLAATO implantation. Abstracts. Ann. Resear. Day. 2007; 15 (21).

30.  Blackshear J., OdellJ. et al. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann.  Thorac.Surg. 1996; 61: 755-759.

31.  Davis   W.,    Hart   R.    Cardiogenic   stroke in the eldery.   Clin.   Geriatr. Med.  1991;  7:429-442.

32.  Stöllberger C.,  Schneider B.,  Finsterer J.Serious complications from dislocation of a WATCHMAN left atrial appendage occluder.J. Cardiovasc. Electrophysiol. 2007; 18: 880-881.

 33. Sick P.,  Schuler G.,  Hauptmann K.  et.  al. Initial   worldwide    experience    with    the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J. Am.Coll. Cardiol. 2007; 49: 1490-1495.

34.  Block P. Watching the WATCHMAN. J. Am.Coll. Cardiol. 2007; 49: 1496-1497.

35.  Meier B.,  Palacios I., Windecker S.  et al.Transcatheter left atrial appendage occlusionwith Amplatzer devices to obviate anticoa-gulation in patients with atrial fibrillation. Cathet. and Cardiovasc. Interv. 2003; 60: 417-422.

36. Gu X., Qian Z., Zhao С et al. Preclinical evaluation of the Amplatzer cardiac Plug to occlude the left atrial appendage in a canine model. Abstracts. Cong. & Struct. Intervent. 2008; 97.